Skip to main content

Table 1 Prevalence of tyroid malignancy at pathology laboratory of GUH from 2010–2013

From: Prevalence and types of thyroid malignancies among thyroid enlarged patients in Gondar, Northwest Ethiopia: a three years institution based retrospective study

Variable Non malignant N (%) Malignant N (%) COR (95% CI) AOR (95% CI)
Sex Male 171(92.4) 14(7.6) 1.05(0.56-1.94)  
Female 613(92.7) 48(7.3) 1  
Age in years 0-10 22(95.7) 1(4.3) 1.5(0.18-12.76) 1.31(.156-11.78)
11-20 231(97.1) 7(2.9) 1  
21-30 236(91.8) 21(8.2) 2.94(1.23-7.04) 2.94(1.19-7.2)
31-40 133(91.7) 12(8.3) 2.98(1.14-7.75) 2.68(0.99-7.22)
41-50 91(91) 9(9) 3.26(1.18-9.03) 3.26(1.14-9.33)
51-60 48(88.9) 6(11.1) 4.13(1.33-12.82) 4.97(1.51-16.33)
>60 23(79.3) 6(20.7) 8.61(2.67-27.78) 10.96(3.15-38.1)
Size in cm 0-1.49 6(100) 0   
1.5-1.99 3(100) 0   
2-2.49 9(90.0) 1(10) 1.41(0.18-11.3) 02.87(0.22-15.98)
3-3.5 6(85.7) 1(14.3) 2.11(0.25-17.83) 2.36(0.236-23.70)
>3.5 760(92.7) 60(7.3) 1 1
Duration of enlargement in year <0.6 years 58(93.5) 4(6.5) 2.48(0.27-23.1)  
0.6-1 year 115(85.8) 19(14.2) 5.95(0.77-46.0)  
2-5 years 365(93.1) 27(6.9) 2.66(0.35-2018)  
6-10 years 160(94.7) 9 (5.3) 2.03(0.25-16.50)  
11-15 years 36(97.3) 1(2.7) 1  
>15 years 50(96.2) 2(3.8) 1.44(0.13-16.50)  
Type of enlargement Solitary 78(78.8) 21(21.2) 9.154(3.75-22.35) 8.82(3.49-22.32)
MNG 468(93.2) 34(6.8) 2.47(1.08-5.66) 2.52(1.07-5.93)
Diffuse 238(97.1) 7(2.9) 1 1
  1. COR: Crude Odds Ratio, AOR: Adjusted Odds Ratio.